For someone experiencing cardiac symptoms in the emergency room, every minute matters as physicians determine whether someone is having a...
The stresses of life have long been thought to increase a person's risk of heart disease. But the question remains...
With a growing movement toward use of targeted therapies, parallel to psoriasis, JAK inhibitors are an important focus of therapeutic research for AD.
AbbVie announced positive top-line results from SELECT-GCA, a Phase III, multicenter, randomized, double-blind, placebo-controlled study, showing upadacitinib (Rinvoq; 15 mg, once daily) in combination with a 26-week steroid taper regimen achieved its primary endpoint of sustained remission from week 12 through week 52 in adults with giant cell arteritis (GCA).
Biogen Idec has announced that results from the daclizumab high-yield process (DAC HYP) SELECT clinical trial have been published as...
A new study published in The Lancet Neurology demonstrates the ability of two blood-based biomarkers to predict how someone will recover from traumatic brain injury (TBI)
Alopecia Areata (AA) is a common autoimmune disease characterized by non-scarring hair loss ranging from patches on the scalp to complete hair loss involving the entire body.
Abbott announced that a new study, published in Lancet Neurology, found that elevated levels of a protein measured with the...
odium zirconium cyclosilicate has been shown to be effective and safe in adults for the treatment of hyperkalaemia, and therefore it is expected to be beneficial in children.